RARE logo

RARE
Ultragenyx Pharmaceutical Inc

2,513
Mkt Cap
$3.49B
Volume
1.59M
52W High
$46.75
52W Low
$25.81
PE Ratio
-6.10
RARE Fundamentals
Price
$36.23
Prev Close
$36.20
Open
$36.39
50D MA
$33.41
Beta
1.04
Avg. Volume
1.38M
EPS (Annual)
-$6.29
P/B
380.81
Rev/Employee
$432,944.36
Loading...
Loading...
News
all
press releases
Howard Horn Sells 3,081 Shares of Ultragenyx Pharmaceutical (NASDAQ:RARE) Stock
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE - Get Free Report) CFO Howard Horn sold 3,081 shares of the firm's stock in a transaction on Wednesday, December 10th. The shares were sold at an average...
MarketBeat·12h ago
News Placeholder
More News
News Placeholder
Frontier Capital Management Co. LLC Invests $19.11 Million in Ultragenyx Pharmaceutical Inc. $RARE
Frontier Capital Management Co. LLC bought a new position in shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE - Free Report) during the second quarter, according to the company in its most...
MarketBeat·17h ago
News Placeholder
Ultragenyx Pharmaceutical (NASDAQ:RARE) CFO Howard Horn Sells 3,081 Shares
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE - Get Free Report) CFO Howard Horn sold 3,081 shares of the firm's stock in a transaction that occurred on Wednesday, December 10th. The shares were sold...
MarketBeat·1d ago
News Placeholder
Bank of Nova Scotia Purchases Shares of 241,985 Ultragenyx Pharmaceutical Inc. $RARE
Bank of Nova Scotia acquired a new position in shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE - Free Report) during the second quarter, according to the company in its most recent disclosure...
MarketBeat·2d ago
News Placeholder
Ultragenyx Pharmaceutical (NASDAQ:RARE) Shares Gap Up - Time to Buy?
Ultragenyx Pharmaceutical (NASDAQ:RARE) Shares Gap Up - What's Next...
MarketBeat·4d ago
News Placeholder
Norges Bank Invests $35.77 Million in Ultragenyx Pharmaceutical Inc. $RARE
Norges Bank purchased a new position in shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE - Free Report) during the 2nd quarter, according to the company in its most recent filing with the...
MarketBeat·5d ago
News Placeholder
Ultragenyx Pharmaceutical Inc. $RARE Holdings Boosted by Hsbc Holdings PLC
Hsbc Holdings PLC grew its stake in shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE - Free Report) by 88.6% in the 2nd quarter, according to its most recent Form 13F filing with the Securities...
MarketBeat·7d ago
News Placeholder
Ultragenyx (RARE) Up 14.4% Since Last Earnings Report: Can It Continue?
Ultragenyx (RARE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·8d ago
News Placeholder
Ultragenyx Pharmaceutical Inc. $RARE Shares Sold by Sands Capital Management LLC
Sands Capital Management LLC reduced its holdings in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE - Free Report) by 5.3% during the second quarter, according to the company in its most recent filing...
MarketBeat·9d ago
News Placeholder
Franklin Resources Inc. Decreases Stake in Ultragenyx Pharmaceutical Inc. $RARE
Franklin Resources Inc. decreased its holdings in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE - Free Report) by 20.9% during the 2nd quarter, according to its most recent disclosure with the SEC. The...
MarketBeat·13d ago

Latest RARE News

View

Advertisement|Remove ads.

Advertisement|Remove ads.